PropertyValue
is ?:annotates of
?:citedBy
  • -1
?:creator
?:doi
  • 10.1007/s00508-021-01922-y
?:doi
?:hasPublicationType
?:journal
  • Wiener klinische Wochenschrift
is ?:pmid of
?:pmid
?:pmid
  • 34378087
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.345
?:rankingScore_hIndex
  • 46
is ?:relation_isRelatedTo_publication of
?:title
  • Safety and immunogenicity of an mRNA-lipid nanoparticle vaccine candidate against SARS-CoV-2 : A phase 1 randomized clinical trial.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all